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Interferon Gamma Release Assay 
Abstract
Early clearance (EC) is the successful eradication of inhaled Mycobacterium tuberculosis before an adaptive immune response develops. Evidence for early clearance comes from case contact studies that consistently show a proportion of heavily exposed individuals do not develop M. tuberculosis infection. Further support for the existence of this phenotype comes from genetic loci associated with tuberculin reactivity. In this review we discuss aspects of the innate response that may underpin EC and hypotheses that can be tested through field laboratory link studies in M. tuberculosis case contacts. Specifically, we consider mechanisms whereby alveolar macrophages recognize and kill intracellular M. tuberculosis, and how other cell types, such as neutrophils, NK T cells, MAIT and γδ T cells may assist. How EC maybe impaired by HIV infection or vitamin D deficiency is also explored. As EC is a form of protective immunity, further study may
Introduction
Mycobacterium tuberculosis is the second most common infectious killer worldwide: in 2013, 9 million people will have been diagnosed with tuberculosis (TB) and 1.2 -1.4 million will die from the disease.
(1) A lack of feasible preventive strategies means the public health response to M. tuberculosis focuses on case finding and management and has a modest impact on transmission. Better preventive strategies are desperately needed, yet efforts to develop a vaccine against infectious pulmonary TB have not been successful. (2) Early Clearance (EC) of M. tuberculosis infection can be defined as the eradication of infecting M. tuberculosis before an adaptive response develops. This phenotype has long been speculated to exist, however its immunological correlates are yet to be described.(3) Identification of the immunological mechanisms behind EC could present new opportunities to prevent M. tuberculosis infection. Firstly EC may be influenced by modifiable host factors that could be therapeutic targets. Secondly EC is a model of protective immunity to M. tuberculosis and its study may yield sought after correlates of protection for vaccine development. (4) For these reasons EC should be prioritized as a focus of M. tuberculosis research. In this review, we discuss putative immunological mechanisms of EC that can serve as hypotheses to be tested in field-laboratory link studies.
Evidence for early clearance
Presently, both epidemiological and genetic data support the existence of EC of M. tuberculosis. Case contact studies repeatedly find exposure to M. tuberculosis does not always lead to a positive Interferon Gamma Release Assay (IGRA) or Tuberculin Skin Test (TST). In 1941 Israel remarked on heavily exposed nursing students: "the persistence of a negative reaction in these students, after the majority of other students had long been infected, is a striking phenomenon." (5) TB case contact studies show that approximately half of exposed persons are TST negative, even in high endemicity settings.(6) M. tuberculosis exposure is a function of duration, proximity and grade of sputum positivity, so EC can be best appreciated when these dimensions of exposure are maximal (Table 1) . (7) Outbreaks in closed environments, such as a US naval ship where 66 sailors shared a cabin with seven others with pulmonary TB, and thirteen remained TST negative after six months, illustrate this best. (8) In such settings it is highly likely M. tuberculosis was inhaled, contained and cleared before an adaptive response developed.
Lurie demonstrated hereditable resistance to M. bovis infection in rabbits in the 1940s.(9) Today, genetic loci associated with TST reactivity have been identified in two populations, suggesting that host factors play an important role in failure to establish an infection after exposure. Recently, Cobat and others used a genome-wide linkage study
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to show TST status is highly hereditable: a single locus accounted for 65% of TST variability in a Columbian population (10) , and two loci determined TST status in South Africa (11) . The first (TST1) is associated with a lack of TST responsiveness and the second (TST2) is associated with the degree of response. Additionally, two candidate gene studies compared TST positive to negative subjects and found associations with cytokine genes. (12, 13) The best explanation for these observations is EC. Alternative explanations can only be discounted by studies that address exposure level as a confounder and reduce the likelihood that a negative TST reflects anergy through post exposure follow up.
Early versus delayed clearance
EC is one of several phenotypes in the progression to TB disease after exposure, ( Figure  1 ). 
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How does early clearance occur?
The alveolar macrophage is the primary target cell of early M. tuberculosis infection.
Recognition by alveolar macrophages, and possibly epithelial cells, leads to pro inflammatory cytokine production,, chemokine secretion and antimicrobial peptides. (20) 
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Mycobacterial killing
Macrophages have a number of mechanisms to kill intracellular mycobacteria. 
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Neutrophils
To date neutrophil responses are the only aspect of EC studied in a prospective cohort of case contacts. Martineau et al found absolute neutrophil count associated with a negative IGRA response and greater killing capacity in a ex vivo Bacille Calmette-Guerin (BCG) lux whole blood stimulation assay. Killing was also assocated with serum levels of the neutrophil antimicrobial peptides, cathelicidin, human neutrophil peptides 1 and 3 and Lipocalin 2. 
NK and T cell subsets

Even less is known about the role of other immune cells in EC. Natural Killer (NK), Mucosa Associated Invariant T (MAIT) cells and γδ T cells express germ-line encoded
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Acquired defects of Early Clearance
A variety of clinical conditions could impair clearance including diabetes mellitus, smoking, end stage renal disease, corticosteriod use and anti-TNF-α agents among others. Conditions where laboratory and clinical observations support impaired clearance are HIV infection and Vitamin D defiency.
HIV
HIV is an established risk factor for developing active TB, and probably also a risk for M. tuberculosis infection. HIV impairs cell-mediated immunity through depletion of CD4 Tcells (70) . Additionally, HIV impairs innate immunity in a manner that may impair EC: macrophage turnover is increased in HIV infection, and apoptosis is impaired (71, 72) ; dendritic cell numbers are diminished and their autophagic and antigen presenting functions are suppressed (73, 74) ; NK cells have low levels of glutathione and permit higher rates of mycobacterial growth in co-cultured monocytes (75) . Molecular epidemiological studies of M. tuberculosis suggest susceptibility to infection is a greater contributor to risk of TB in HIV positive persons than accellerated disease progression. HIV was strongly associated with reinfection in a study of previously treated South African miners. (76) Additionally, a metaanalysis of molecular epidiological studies shows high rates of clustering of M. tuberculosis strains, supporting susceptibility to infection rather than reactiviation of previously circulating strains. (77) A low baseline
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Further research and conclusions
EC is a priority for M. tuberculosis research as such studies have potential to discover new immunotherapies and vaccines to prevent infection. Case contact studies allow EC to be observed in humans, through the integration of immunological phenotyping with a
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well established field study design. (90) This approach is analogous to the study of highly exposed persistently negative sex workers to identify broadly neutralising antibodies to HIV, now recognised as a new avenue for HIV vaccine development. Case contact studies allow investigators to quantify and adjust for environmental and pathogen factors, so host factors can be studied without confounding. Specifically, duration of index case infectivity, proximity and frequency of contact, sputum bacillary burden and strain type. Long term follow up of putative ECs, potentially over decades, can strengthen confidence that persistent TST negativity is in fact clearance, not anergy.
Identifying and validating biomarkers is a necessary first step for EC research. This will provide supporting evidence for EC as a distinct phenotype, assist in easier identification of ECs in future studies, and suggest possible mechanisms of EC. Biomarkers may also enable study of EC in HIV, which is presently limited by the poor sensitivity of TST and IGRA. Other M. tuberculosis phenotypes have been studied in this way, for example, the cytokine and cell populations that distingush LTBI progressors from non progressors. (91) Additionally, the effect of ex vivo M. tuberculosis stimulation on cytokine production or gene transciption can be studied for its correlation with phenotype. (92) A challenge in EC research will be to assess the events that occur in the lungs of healthy case contacts. Some biomarkers may be detectable in blood, whereas others might only be found on bronchoalveolar lavage. The latter has been proposed though its invasiveness and complexity limits its use in large studies. (93) In 
